Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6831003 | Seizure | 2015 | 4 Pages |
Abstract
Failure to prescribe valproate for IGE, particularly when another first-line treatment has failed, may not be in a young woman's best interests-particularly when they are most vulnerable to sequelae from uncontrolled seizures. Indiscriminate avoidance of valproate needs to be recognised as a misinterpretation of current epilepsy guidelines as it may harm young people. Although the use of valproate demands careful consideration, there remains a strong case to always discuss this medication because of its efficacy and potential to reduce seizure-related harm. Patients must be allowed to make their own informed decisions about effective epilepsy treatments.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Tom B. Mole, Richard Appleton, Anthony Marson,